NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637105. A total of 42 filers reported holding NABRIVA THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $116,000 | -31.0% | 33,461 | 0.0% | 0.00% | – |
| Q1 2018 | $168,000 | -92.0% | 33,461 | -90.4% | 0.00% | -100.0% |
| Q4 2017 | $2,093,000 | -27.0% | 350,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,867,000 | -27.1% | 350,000 | 0.0% | 0.00% | -50.0% |
| Q2 2017 | $3,931,000 | – | 350,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|